Tag: INFA

Finance

Eye Catching Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Informatica (NASDAQ:INFA), Canadian Pacific Railway Limited (NYSE:CP), EnLink Midstream, LLC (NYSE:ENLC), Trex (NYSE:TREX)

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. Currently there are 5 analysts that rate ARIAD Pharmaceuticals a buy, no analysts rate it a sell, and 6 rate it a hold. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)’s stock on 31 July traded at beginning with a price of $6.03 and when day-trade ended the stock … Continue reading Eye Catching Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Informatica (NASDAQ:INFA), Canadian Pacific Railway Limited (NYSE:CP), EnLink Midstream, LLC (NYSE:ENLC), Trex (NYSE:TREX)

John Meady
Analysis, BioTech, Finance, Financial, Semiconductors, Software

INFA Reports Strong Quarter Despite Macro Headwinds

Informatica reported solid first-quarter results with revenue growth slightly exceeding expectations, as increased hiring and investment weighed on margins.  The firm grew revenue 9.3% from the year-ago period to $214.3 million, 5% ahead of our model. Informatica changed the way it reports revenues by giving more details, which we find helpful. Service revenue was strong, gaining 14.8% year over year to $126.4 million. The Consulting … Continue reading INFA Reports Strong Quarter Despite Macro Headwinds

Mark DoerrLeave a comment